Foster City, CA, United States of America

Todd C Somers

This inventor holds 15 USPTO granted patents, primarily in Pharmaceutical Research. Top assignees: Genentech, Inc., The University of Texas System, Other. Active years: 1993-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Todd C Somers. Retrieved from https://idiyas.com/inventor/todd-c-somers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 93.3

Average Co-Inventor Count = 4.4

ph-index = 7

Forward Citations = 248(Granted Patents)


Location History:

  • Montara, CA (US) (1993 - 1997)
  • San Carlos, CA (US) (2001)
  • Foster City, CA (US) (1998 - 2006)

Company Filing History:


Years Active: 1993-2006

Loading Chart...
Areas of Expertise:
Peptidomimetic
Growth Hormone
Secretagogues
Ras Farnesyl Transferase
Integrin Inhibitors
Tricyclic Inhibitors
GPIIb IIIa Receptor
Nonpeptidyl
Ketamine Analogues
Thrombocytopenia
Vitronectin Receptor
15 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Todd C. Somers

Introduction

Todd C. Somers, an inventor based in Foster City, CA, has made significant strides in the field of biotechnology with an impressive portfolio of 14 patents. His work primarily focuses on growth hormone secretagogues and their applications in promoting growth and treating various medical conditions.

Latest Patents

Among his most notable inventions are the low molecular weight peptidomimetic growth hormone secretagogues. These growth hormone releasing peptides, known as GHRP, are designed to stimulate the release of growth hormone from the pituitary gland. The compositions derived from Somers’s inventions are particularly valuable, being utilized to promote growth in mammals either independently or in conjunction with other growth-promoting compounds, especially Insulin-like Growth Factor 1 (IGF-1). Furthermore, his innovative methods utilize GHRP and IGF-1 to potentially aid in the treatment of Type II diabetes, showcasing his commitment to advancing healthcare solutions.

Career Highlights

Todd C. Somers has been affiliated with renowned companies such as Genentech, Inc. and the University of Texas System. His experiences at these institutions have equipped him with a wealth of knowledge and expertise in developing cutting-edge innovations in the biopharmaceutical sector.

Collaborations

Throughout his career, Somers has worked alongside notable colleagues, including Robert S. McDowell and Brent K. Blackburn. These collaborations have fostered a creative environment that enhances the potential for groundbreaking discoveries and advancements.

Conclusion

In summary, Todd C. Somers stands out as a prominent figure in the realm of biotechnology through his inventive contributions, particularly in the area of growth hormone secretagogues. His work continues to inspire innovation and may have lasting impacts on growth promotion and diabetes treatment. With a dedicated career of ingenuity, Somers exemplifies the spirit of invention that drives the future of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…